Department of Orthopedics, University of Colorado School of Medicine, Aurora, Colorado.
Department of Orthopaedics, Seton-Hall Hackensack Meridian School of Medicine, South Orange, New Jersey.
Sports Health. 2018 Sep/Oct;10(5):453-461. doi: 10.1177/1941738118758312. Epub 2018 Feb 22.
Previous studies have analyzed the treatment patterns used to manage injuries in National Football League (NFL) players.
Treatment patterns for injuries in NFL players will have changed over the study period.
Descriptive epidemiology study.
Level 5.
The head orthopaedic team physicians for all 32 NFL teams were asked to complete a survey containing questions regarding experience as team physician, medical coverage of the team, and treatment preferences for some of the most common injuries occurring in football players. Responses from the current survey were compared with responses from the same survey sent to NFL team physicians in 2008.
Responses were received from 31 (31/32, 97%) NFL team physicians in 2008 and 29 (29/32, 91%) NFL team physicians between April 2016 and May 2017. The proportion of physicians preferring patellar tendon autograft in anterior cruciate ligament (ACL) reconstruction increased from 87% in 2008 to 97% in 2016 ( P = 0.054). In 2008, 49% of physicians allowed return to contact after ACL reconstruction at 6 months or less as compared with only 14% of physicians in 2016 ( P = 0.033). In 2008, 93% of physicians used Toradol injections prior to a game to help with nagging injuries. Toradol injection utilization decreased to 48% of physicians in 2016 ( P < 0.001). Seventy-nine percent of physicians would administer 5 or more Toradol injections prior to a game in 2008, as compared with 28% of physicians in 2016 ( P < 0.0001).
Orthopaedic physicians have changed their injury treatment preferences for professional football players. In particular, physicians have become more cautious with allowing players to return to play after ACL reconstruction and with the use of pregame Toradol injections.
Expert opinions can help guide treatment decisions and lead to better care of all athletes.
之前的研究已经分析了美国国家橄榄球联盟（NFL）运动员受伤的治疗模式。
NFL 运动员的受伤治疗模式在研究期间发生了变化。
描述性流行病学研究。
5 级。
要求所有 32 支 NFL 球队的骨科队医完成一份包含有关队医经验、球队医疗覆盖范围以及一些最常见足球运动员受伤治疗偏好的问题的调查。将当前调查的回复与 2008 年向 NFL 队医发送的相同调查的回复进行比较。
2008 年收到 31 名（31/32，97%）NFL 队医的回复，2016 年 4 月至 2017 年 5 月期间收到 29 名（29/32，91%）NFL 队医的回复。在前交叉韧带（ACL）重建中更喜欢使用髌腱自体移植物的医生比例从 2008 年的 87%增加到 2016 年的 97%（P=0.054）。2008 年，49%的医生允许 ACL 重建后在 6 个月或更短时间内恢复接触，而 2016 年只有 14%的医生允许（P=0.033）。2008 年，93%的医生在比赛前使用特乐定注射以帮助治疗恼人的伤病。2016 年，特乐定注射的使用率下降至 48%（P<0.001）。2008 年，79%的医生会在比赛前给 5 次或更多的特乐定注射，而 2016 年只有 28%的医生会这样做（P<0.0001）。
骨科医生已经改变了他们对职业足球运动员受伤的治疗偏好。特别是，医生在允许 ACL 重建后的球员重返比赛以及使用赛前特乐定注射方面变得更加谨慎。
专家意见可以帮助指导治疗决策，并为所有运动员提供更好的护理。
